Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aspirin Resistance”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableStudy completedNCT01406990
What this trial is testing

Aspirin Responsiveness in Women With Coronary Artery Disease

Who this might be right for
CAD
Creighton University 15
Not applicableEnded earlyNCT01788930
What this trial is testing

Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients

Who this might be right for
AtherothrombosisType 2 DiabetesObstructive Sleep Apnea Syndrome
University Hospital, Grenoble 53
Not applicableLooking for participantsNCT06802861
What this trial is testing

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

Who this might be right for
PreeclampsiaPreeclampsia (PE)Preeclampsia (PE) Risk+6 more
University of Tennessee Graduate School of Medicine 50
Large-scale testing (Phase 3)Study completedNCT01586975
What this trial is testing

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Who this might be right for
StrokeMyocardial Infarctions
Northwestern University 93
Not applicableStudy completedNCT01432652
What this trial is testing

The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery

Who this might be right for
Aspirin Resistance
University of Lausanne Hospitals 45
Not applicableUnknownNCT03532698
What this trial is testing

Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IVEGFR T790M
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 100
Post-approval studies (Phase 4)Study completedNCT00129038
What this trial is testing

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Who this might be right for
Coronary Arteriosclerosis
Boehringer Ingelheim 11
Not applicableStudy completedNCT01212302
What this trial is testing

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)

Who this might be right for
Coronary Artery Disease
Ruhr University of Bochum 500
Post-approval studies (Phase 4)UnknownNCT02055131
What this trial is testing

Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis

Who this might be right for
Thrombosis
Tunis University 300
Not applicableUnknownNCT05151263
What this trial is testing

Prevalence of Aspirin Resistance in Ischemic Stroke Patients at Assiut University Hospital

Who this might be right for
Ischemic Stroke
Assiut University 133
Not applicableStudy completedNCT00742430
What this trial is testing

Resistance on Antithrombotic Drugs in Ischemic Heart Disease

Who this might be right for
Coronary Artery Disease
University of Zagreb 141
Post-approval studies (Phase 4)Study completedNCT00446641
What this trial is testing

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

Who this might be right for
Cerebral Infarction
Asan Medical Center 244
Testing effectiveness (Phase 2)Study completedNCT03543683
What this trial is testing

Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IVEGFR T790M
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 115
Large-scale testing (Phase 3)Looking for participantsNCT06740916
What this trial is testing

Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance

Who this might be right for
Myeloproliferative Neoplasms (MPN)
Siriraj Hospital 240
Post-approval studies (Phase 4)Study completedNCT00222261
What this trial is testing

Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.

Who this might be right for
Coronary Heart DiseaseAngina PectorisAtherosclerosis
Ullevaal University Hospital 1,001
Post-approval studies (Phase 4)Ended earlyNCT00289601
What this trial is testing

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

Who this might be right for
Angioplasty
Brigham and Women's Hospital 1,200
Not applicableStudy completedNCT00761891
What this trial is testing

Validation of an Assay to Measure Cyclooxygenase-1 Activity

Who this might be right for
Healthy
Vanderbilt University 64
Post-approval studies (Phase 4)Study completedNCT01159639
What this trial is testing

Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting

Who this might be right for
Coronary Artery DiseaseAspirin Resistance
University of Zagreb 200
Not applicableStudy completedNCT00898950
What this trial is testing

Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

Who this might be right for
Diabetes Type 2
University of Portsmouth 21
Not applicableUnknownNCT06215300
What this trial is testing

The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.

Who this might be right for
to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting
Novosibirsk Scientific Research Institute for Circulatory Pathology 800
Load More Results